Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Packer

Showing results (291-300 of 4,797) with videos related to

Pageof 480
Sort By:
Nature Reviews. Cardiology|June 13, 2022
Six lessons learned from the use of SGLT2 inhibitors in patients with heart failureMilton Packer
Journal of Cardiac Failure|March 6, 2024
The Ideal Heart Rate for Heart Failure and Ejection Fraction > 40%: Both Myth and Magic?Milton Packer
Annals of Internal Medicine|August 1, 1985
Vasodilator therapy for primary pulmonary hypertension. Limitations and hazardsM Packer
BMJ (Clinical Research Ed.)|September 16, 2016
Data sharing: lessons from Copernicus and KeplerMilton Packer
Journal of the American College of Cardiology|April 10, 2024
SGLT2 Inhibition: Neither a Diuretic nor a NatriureticMilton Packer
Biological Chemistry|May 30, 2002
Highlight: oxidative stressLester Packer
The American Journal of Medicine|February 17, 2020
Does Metformin Interfere With the Cardiovascular Benefits of SGLT2 Inhibitors? Questions About Its Role as the Cornerstone of Diabetes TreatmentMilton Packer
European Journal of Heart Failure|February 11, 2020
Autophagy stimulation and intracellular sodium reduction as mediators of the cardioprotective effect of sodium-glucose cotransporter 2 inhibitorsMilton Packer
Journal of Cardiac Failure|September 5, 2020
Uric Acid Is a Biomarker of Oxidative Stress in the Failing Heart: Lessons Learned from Trials With Allopurinol and SGLT2 InhibitorsMilton Packer
American Journal of Nephrology|March 4, 2020
Mitigation of the Adverse Consequences of Nutrient Excess on the Kidney: A Unified Hypothesis to Explain the Renoprotective Effects of Sodium-Glucose Cotransporter 2 InhibitorsMilton Packer
Pageof 480

Showing results (291-300 of 4,797) with videos related to

Sort By:
Pageof 480
Nature Reviews. Cardiology|June 13, 2022
Six lessons learned from the use of SGLT2 inhibitors in patients with heart failureMilton Packer
Journal of Cardiac Failure|March 6, 2024
The Ideal Heart Rate for Heart Failure and Ejection Fraction > 40%: Both Myth and Magic?Milton Packer
Annals of Internal Medicine|August 1, 1985
Vasodilator therapy for primary pulmonary hypertension. Limitations and hazardsM Packer
BMJ (Clinical Research Ed.)|September 16, 2016
Data sharing: lessons from Copernicus and KeplerMilton Packer
Journal of the American College of Cardiology|April 10, 2024
SGLT2 Inhibition: Neither a Diuretic nor a NatriureticMilton Packer
Biological Chemistry|May 30, 2002
Highlight: oxidative stressLester Packer
The American Journal of Medicine|February 17, 2020
Does Metformin Interfere With the Cardiovascular Benefits of SGLT2 Inhibitors? Questions About Its Role as the Cornerstone of Diabetes TreatmentMilton Packer
European Journal of Heart Failure|February 11, 2020
Autophagy stimulation and intracellular sodium reduction as mediators of the cardioprotective effect of sodium-glucose cotransporter 2 inhibitorsMilton Packer
Journal of Cardiac Failure|September 5, 2020
Uric Acid Is a Biomarker of Oxidative Stress in the Failing Heart: Lessons Learned from Trials With Allopurinol and SGLT2 InhibitorsMilton Packer
American Journal of Nephrology|March 4, 2020
Mitigation of the Adverse Consequences of Nutrient Excess on the Kidney: A Unified Hypothesis to Explain the Renoprotective Effects of Sodium-Glucose Cotransporter 2 InhibitorsMilton Packer
Pageof 480